Ganeden Receives FDA GRAS on Probiotic-Derived Immune Health Ingredient: Staimune

Food and Healthcare Press Releases Thursday June 8, 2017 12:32
CLEVELAND--8 Jun--PRNewswire/InfoQuest
New patented offering expands immunity formulations in functional foods and beverages

Ganeden, already known as a leader in probiotic technology, has used its patented probiotic strain to develop an immune health ingredient: Staimune(TM). The new ingredient utilizes the cells of the probiotic GanedenBC30(R) to support immune health, at cost effective inclusion levels. Available later this summer, Ganeden anticipates Staimune to be an industry-changing development.

Officially identified as "Inactivated Bacillus coagulans GBI-30, 6086", Staimune's ease of formulation opens up new opportunities in functional foods and beverages—most importantly in shelf-stable beverages and high-water-activity products. Staimune is FDA GRAS, non-GMO, organic compliant and kosher, making it extremely accessible for use in a vast amount of applications.

Multiple peer-reviewed and published studies show the immune health benefits of GanedenBC30 cells, with additional in-vitro and human clinical studies on Staimune currently underway.

"After seeing the impressive immune supporting benefits of GanedenBC30, we decided to dive further into the mechanism of action," said Michael Bush, president and CEO of Ganeden. "We discovered and ultimately patented this novel ingredient which provides the opportunity to share the immune benefits of the probiotic in product formats that do not support the use of the live organism."

Staimune provides the option for manufacturers that want to focus specifically on immune health, and for those with processes that cause formulation challenges for live probiotics. With an inclusion rate of just 50mg, Staimune does not alter the flavor or texture profiles of finished goods, allowing for easy application into a large number of product categories.

Staimune will be available for formulation starting in the summer of 2017. For more information on the immune health ingredient and Ganeden's other probiotic technologies, visit GanedenProbiotics.com.
About Ganeden:

Ganeden(R) is at the forefront of probiotic research and product development with an extensive library of published studies and more than 135 patents for probiotic technologies in the supplement, food, beverage, animal health, sports nutrition and personal care ingredients markets. Ganeden is best known for GanedenBC30(R) its patented, FDA GRAS and highly stable probiotic ingredient. Through the fermentation process of GanedenBC30, Ganeden developed Bonicel(R), the first science-backed, probiotic-derived, personal care ingredient shown to dramatically reduce signs of aging. Ganeden's newest ingredient, Staimune(TM) is a patented probiotic technology comprising of inactivated GanedenBC30 cells, which have immune benefits. For more information about Ganeden and licensing opportunities, visit GanedenProbiotics.com.

Logo - https://mma.prnewswire.com/media/458885/Ganeden_Logo.jpg
Logo - https://mma.prnewswire.com/media/520839/Staimune_Logo.jpg

Latest Press Release

Menarini Progresses Into the Clinic With MEN1611, a PI3K Inhibitor for the Treatment of HER2 Positive Metastatic Breast Cancer

Menarini Ricerche announced today the initiation of the B-PRECISE-01 clinical trial, a multicenter phase Ib study that will evaluate the safety and efficacy of MEN1611 plus trastuzumab with or without fulvestrant. The study will enroll patients with...

Don#t Miss the Signs of a Breaking Spine, Warns IOF

Osteoporosis, a disease which causes bones to become weak and fragile, is the cause of broken bones in approximately one in three women and one in five men aged over 50 worldwide. (Photo: https://mma.prnewswire.com/media/767079/IOF_Infographic.jpg...

Merck Inaugurates State-of-the-art Pharma Packaging Center in Darmstadt

- Expansion of the pharma manufacturing site at Merck's headquarters supports growth of current and future portfolio of pharma medicines - New building dedicated to the packaging and shipping of Merck's pharma medicines in more than 90 countries - EUR63...

Herbalife Nutrition Survey Reveals Secrets to Healthy Aging, Announces Wellness Tour to Kickstart APAC Consumers# Healthy Aging Journey

As a company whose purpose is to make the world healthier and happier, premier global nutrition company, Herbalife Nutrition, today released findings from its 2018 Asia Pacific Healthy Aging Survey. Conducted in August 2018 with 5,500 respondents aged 40...

Global Survey and Documentary Film Expose Emotional Impact of Multiple Sclerosis

- Merck-sponsored survey developed in collaboration with IACO and Eurocarers reveals lifelong effects of caring for a loved one with MS - #MSInsideOut documentary film, executively produced by Shift.ms, provides artistic take on the experiences of those...

Related Topics